Aspira Pathlab & Diagnostics Limited (BOM:540788)
India · Delayed Price · Currency is INR 64.30
-0.01 (-0.02%)
At close: Sep 1, 2025
BOM:540788 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
| 226.1 | 219.99 | 132.05 | 144.57 | 195.42 | 152.05 | Upgrade | |
Revenue Growth (YoY) | 71.22% | 66.60% | -8.66% | -26.02% | 28.52% | 80.66% | Upgrade |
Cost of Revenue | 122.76 | 122.9 | 97.88 | 88.63 | 95.62 | 88.58 | Upgrade |
Gross Profit | 103.34 | 97.09 | 34.17 | 55.94 | 99.8 | 63.47 | Upgrade |
Selling, General & Admin | - | 2.7 | 3.15 | 5.16 | 2 | 3.94 | Upgrade |
Other Operating Expenses | 63.37 | 58.83 | 42.9 | 34.85 | 34.06 | 24.4 | Upgrade |
Operating Expenses | 78.19 | 76.46 | 61.43 | 55.86 | 52.42 | 42.78 | Upgrade |
Operating Income | 25.14 | 20.63 | -27.26 | 0.08 | 47.38 | 20.69 | Upgrade |
Interest Expense | -3.6 | -3.05 | -3.17 | -3.67 | -3.08 | -7.88 | Upgrade |
Interest & Investment Income | - | 3.69 | 3.99 | 2.91 | 0.95 | 2.04 | Upgrade |
Earnings From Equity Investments | -1.62 | -0.5 | - | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | 4.05 | -0.23 | -0.45 | -0.33 | -0.65 | -1.03 | Upgrade |
EBT Excluding Unusual Items | 23.97 | 20.54 | -26.89 | -1.01 | 44.59 | 13.81 | Upgrade |
Gain (Loss) on Sale of Assets | - | -0.32 | - | 0.04 | - | - | Upgrade |
Other Unusual Items | - | 0.01 | 0.17 | 0.08 | - | - | Upgrade |
Pretax Income | 23.97 | 20.23 | -26.72 | -0.89 | 44.59 | 13.81 | Upgrade |
Net Income | 23.97 | 20.23 | -26.72 | -0.89 | 44.59 | 13.81 | Upgrade |
Net Income to Common | 23.97 | 20.23 | -26.72 | -0.89 | 44.59 | 13.81 | Upgrade |
Net Income Growth | - | - | - | - | 222.91% | - | Upgrade |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade |
Shares Change (YoY) | 1.84% | - | - | - | 8.12% | 11.07% | Upgrade |
EPS (Basic) | 2.29 | 1.97 | -2.60 | -0.09 | 4.33 | 1.45 | Upgrade |
EPS (Diluted) | 2.29 | 1.97 | -2.60 | -0.09 | 4.33 | 1.45 | Upgrade |
EPS Growth | - | - | - | - | 198.62% | - | Upgrade |
Free Cash Flow | - | 14.83 | 7.92 | -1.43 | 14.32 | 55.5 | Upgrade |
Free Cash Flow Per Share | - | 1.44 | 0.77 | -0.14 | 1.39 | 5.83 | Upgrade |
Gross Margin | 45.70% | 44.14% | 25.88% | 38.69% | 51.07% | 41.74% | Upgrade |
Operating Margin | 11.12% | 9.38% | -20.64% | 0.05% | 24.24% | 13.61% | Upgrade |
Profit Margin | 10.60% | 9.19% | -20.24% | -0.61% | 22.82% | 9.08% | Upgrade |
Free Cash Flow Margin | - | 6.74% | 6.00% | -0.99% | 7.33% | 36.50% | Upgrade |
EBITDA | 41.81 | 28.2 | -19.23 | 8.08 | 56.79 | 30.04 | Upgrade |
EBITDA Margin | 18.49% | 12.82% | -14.56% | 5.59% | 29.06% | 19.75% | Upgrade |
D&A For EBITDA | 16.67 | 7.57 | 8.02 | 8.01 | 9.42 | 9.35 | Upgrade |
EBIT | 25.14 | 20.63 | -27.26 | 0.08 | 47.38 | 20.69 | Upgrade |
EBIT Margin | 11.12% | 9.38% | -20.64% | 0.05% | 24.24% | 13.61% | Upgrade |
Revenue as Reported | 230.15 | 223.88 | 136.26 | 147.78 | 196.37 | 154.09 | Upgrade |
Advertising Expenses | - | 2.33 | 2.66 | 2.66 | 1.65 | 3.93 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.